Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

BACKGROUND: Immune checkpoint inhibitors have revolutionized treatment and improved survival in many cancers. However, since immune-related adverse events (irAEs) are potentially fatal, early recognition and prompt treatment are warranted. One of the rarest but most dramatic irAE is myocarditis, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Monge, Cecilia, Maeng, Hoyoung, Brofferio, Alessandra, Apolo, Andrea B., Sathya, Bharath, Arai, Andrew E., Gulley, James L., Bilusic, Marijo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299503/
https://www.ncbi.nlm.nih.gov/pubmed/30563577
http://dx.doi.org/10.1186/s40425-018-0473-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299503/
https://www.ncbi.nlm.nih.gov/pubmed/30563577
http://dx.doi.org/10.1186/s40425-018-0473-0

Ejemplares similares